USPH Q1 2025: Injury Prevention Revenue Jumps 29%, Offsetting Medicare Headwinds
US Physical Therapy’s first quarter saw a record start in visits per clinic per day and double-digit EBITDA growth, as the company’s injury prevention segment surged and commercial rate gains outpaced ongoing Medicare reimbursement cuts. Despite weather disruptions and continued wage pressures, management highlighted operational resilience, margin rebound in March, and expanding home care and workers’ comp initiatives as key levers for 2025 growth.
Summary
- Injury Prevention Outperformance: Segment delivered 29% revenue growth, balancing reimbursement and wage pressure.
- Commercial Rate Gains: Net rate per visit rose despite a fifth straight year of Medicare cuts.
- Margin Focus: March margin exceeded 20%, with leadership pressing for sustained improvement through cost discipline and rate actions.
Performance Analysis
US Physical Therapy’s core business delivered a strong start to 2025, setting a new first-quarter record for average visits per clinic per day at 31.4, despite severe winter weather that caused approximately 26,000 lost visits, primarily in key mature markets like Nashville and Texas. The company’s physical therapy segment generated $156.4 million in revenue, up 16.4% year over year, largely driven by the November 2024 Metro acquisition, which contributed nearly $17 million in revenue and is now the company’s largest partnership. Excluding the impact of acquisitions, underlying volume and rate trends remained positive, with net rate per visit increasing by $2.29 year over year to $105.66, even as Medicare reimbursement declined by 2.9%.
The Industrial Injury Prevention (IIP) segment was a standout, posting 29% revenue and profit growth, with organic IIP revenue up 15.1% and gross profit up 13.1% excluding acquisitions. The segment’s margin held steady at 20.4%. Company-wide, adjusted EBITDA rose 16.5%, supported by improved rates, workers’ comp mix, and strict cost management. Operating margins rebounded sharply in March, exceeding 20%, after weather and acquisition mix diluted results earlier in the quarter. Corporate office costs declined as a percentage of revenue, and the balance sheet remains healthy, with moderate leverage and ample liquidity to fund further acquisitions.
- Weather Impact Concentrated: Severe winter storms hit mature clinics in core markets, but volumes rebounded by March.
- Metro Acquisition Drives Scale: Metro’s high-volume clinics are now central to growth strategy and margin improvement initiatives.
- Workers’ Comp Mix Expands: Workers’ comp revenue rose to 10.9% of mix, the highest since 2020, supporting net rate gains.
Management emphasized that margin improvement and rate actions, particularly in the Metro partnership, are central to offsetting wage inflation and regulatory reimbursement risk in the coming quarters.
Executive Commentary
"Our margin for the quarter was okay. But if you look at our margin progression, particularly where we ended up in March, March was a 21-day month for us this quarter, average month, you know, over the course of the year. We ended up with nicely above a 20% margin there. Now we've got to continue that. We're working very hard with the ops team directly involved with the top 40 partnerships on trying to move the needle directionally where we needed to be. Guys are familiar with the headwinds that we faced. We're making progress. We expect to make continued progress. I feel better about that than I have in some time."
Chris Redding, Chairman and CEO
"Our average visits per day in the first quarter were a record high for any first quarter in our history at 31.4. We lost about 26,000 visits due to weather in the first quarter. But the underlying volume in the business was strong. Our net rate for the first quarter was $105.66. That was a really good mark, particularly when you think about the fact that we had the Medicare rate reduction that went into effect at the beginning of the year."
Kerry Hendrickson, Chief Financial Officer
Strategic Positioning
1. Rate and Payer Mix Management
USPH’s core strategic lever is active rate negotiation and payer mix optimization, with a focus on commercial and workers’ comp contracts to counteract a fifth consecutive year of Medicare cuts. The company’s payer contracting team, supported by analytics partner Payrology, is targeting top payers across its largest partnerships, with recent wins including Blue Cross Blue Shield contracts in Texas and Metro’s Northeast footprint. Workers’ comp as a share of revenue climbed to 10.9%, up from 9.3% two years ago, directly supporting net rate resilience.
2. Acquisition and Integration Discipline
Acquisitions remain the primary capital allocation priority, with the Metro deal now central to the company’s scale and margin agenda. Metro’s high-volume clinics, unique home care capabilities, and cradle-to-grave care model are providing templates for broader network adoption. Management is deploying a rigorous, data-driven approach to integrating acquired clinics, benchmarking productivity, rate, and cost metrics across the top 40 partnerships (representing 75%–80% of earnings) to drive margin harmonization and operational discipline.
3. Diversification Through Injury Prevention and Home Care
The Industrial Injury Prevention (IIP) business is now a material growth engine, benefiting from both organic expansion and recent acquisitions. The segment’s sticky contracts, focus on measurable injury reduction, and growing government business provide both margin stability and greenfield opportunity. The home care channel, inherited from Metro, is being piloted across the network, targeting the homebound patient segment with a profitable, visit-based reimbursement model that avoids traditional overhead. Leadership views this as a flexible, site-agnostic care delivery lever to capture incremental demand and clinician preference flexibility.
4. Margin Recovery and Cost Control
Margin expansion is a top operational priority, particularly after wage and benefit inflation in 2024 pressured cost per visit. Management’s direct involvement with partnership leaders, focus on productivity, and targeted cost benchmarking are designed to restore margin levels seen pre-pandemic. Corporate office costs have declined as a share of revenue, and further cost containment is expected as integration and process improvements scale.
5. Policy Advocacy and Regulatory Navigation
USPH is deeply engaged in industry lobbying to reverse or mitigate Medicare cuts, with leadership active in APTQI and legislative advocacy for payment reform and PT-led case management models. While management is realistic about the near-term prospects for a permanent fix, they are positioning the business to absorb further regulatory volatility through payer mix and rate management.
Key Considerations
The quarter’s results highlight a company actively managing through reimbursement headwinds, wage inflation, and episodic weather disruptions by leaning on diversified revenue streams and disciplined rate optimization.
Key Considerations:
- Injury Prevention as a Growth Engine: IIP’s sustained double-digit growth and sticky contracts provide a buffer against cyclical clinic volumes and reimbursement risk.
- Metro Acquisition Integration: Metro’s performance and integration are now central to both top-line growth and margin recovery; further rate lifts are expected as new contracts take effect.
- Home Care Flexibility: Home care is being piloted as a profitable, site-agnostic delivery channel for hard-to-reach patients, with potential for broader network rollout.
- Active Margin Management: Direct CEO involvement in partnership benchmarking and cost control signals a heightened focus on restoring pre-pandemic margin levels.
- Workers’ Comp Expansion: Growing workers’ comp mix supports rate resilience and diversifies away from Medicare exposure.
Risks
Medicare reimbursement remains a structural headwind, with five consecutive years of cuts amounting to a $20 million annual profit impact. Wage inflation, staffing constraints, and potential recessionary demand softness could pressure margins or limit volume growth. Policy advocacy for payment reform faces political gridlock, and integration risk around recent acquisitions, particularly Metro, must be monitored for both financial and operational execution. Weather volatility and geographic concentration in certain markets add further unpredictability.
Forward Outlook
For Q2 2025, USPH did not provide specific quantitative guidance but signaled:
- Expectations for continued volume strength and margin improvement as weather headwinds abate and recent rate actions take effect.
- Further integration of Metro and ongoing acquisition pipeline activity, with additional centers expected to open or be acquired in the coming quarters.
For full-year 2025, management withheld updated guidance, citing a desire for a few more months of data but acknowledged performance is tracking ahead of internal projections year to date. Key drivers for the remainder of the year include sustained rate growth, margin recovery, and expansion of injury prevention and home care offerings.
Takeaways
USPH delivered a record Q1 in visits per clinic per day, with strong IIP growth and early signs of margin rebound. The company’s ability to offset Medicare cuts through commercial and workers’ comp rate gains, combined with disciplined acquisition and cost management, positions it for further growth and margin recovery in 2025.
- Injury Prevention Growth: IIP’s 29% revenue increase and stable margins provide a critical offset to reimbursement and wage headwinds, with greenfield opportunity ahead.
- Metro as a Strategic Lever: Metro’s high-volume clinics and home care capabilities are now central to USPH’s growth, integration, and rate management strategies.
- Margin and Rate Execution: Sustained focus on margin recovery, rate negotiation, and cost discipline will determine the trajectory of earnings growth in the coming quarters.
Conclusion
USPH’s Q1 2025 results demonstrate a business adapting to persistent reimbursement pressure and wage inflation by leveraging diversified growth engines, disciplined rate management, and operational rigor. The company’s focus on injury prevention, home care, and acquisition integration offers multiple levers for sustained growth and improved profitability as the year progresses.
Industry Read-Through
USPH’s experience underscores the urgency for outpatient healthcare providers to diversify revenue streams and aggressively manage payer mix as Medicare reimbursement pressure intensifies. The success of the IIP segment and home care pilots highlights the growing value of ancillary and flexible delivery models in the post-acute space. For the broader sector, disciplined acquisition integration, cost benchmarking, and local rate negotiation are emerging as critical tools for margin defense. Policy uncertainty and labor market tightness remain sector-wide risks, but those able to scale diversified services and maintain pricing power are best positioned for resilient growth.